Provided by Tiger Fintech (Singapore) Pte. Ltd.

Camp4 Therapeutics Corp.

1.65
+0.02001.23%
Post-market: 1.650.00000.00%17:32 EDT
Volume:75.87K
Turnover:123.38K
Market Cap:33.26M
PE:-0.31
High:1.74
Open:1.61
Low:1.55
Close:1.63
Loading ...
Jun 13, 2025

Major Issues Report

Form 8-K - Current report
May 16, 2025

Major Issues Report

Form 8-K - Current report
May 13, 2025

Major Issues Report

Form 8-K - Current report
May 13, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Mar 28, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Mar 28, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 27, 2025

Major Issues Report

Form 8-K - Current report
Mar 18, 2025

Major Issues Report

Form 8-K - Current report
Jan 07, 2025

Major Issues Report

Form 8-K - Current report
Nov 21, 2024

Major Issues Report

Form 8-K - Current report
Nov 21, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 22, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Oct 22, 2024

Beneficial Ownership Change

Form SC 13D - General Statement of Acquisition of Beneficial Ownership
Oct 22, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Oct 22, 2024

Beneficial Ownership Change

Form SC 13D - General Statement of Acquisition of Beneficial Ownership
Oct 22, 2024

Beneficial Ownership Change

Form SC 13D - General Statement of Acquisition of Beneficial Ownership
Oct 16, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Oct 15, 2024

Major Issues Report

Form 8-K - Current report
Oct 09, 2024

Correspondence

Form CORRESP - Correspondence
Oct 09, 2024

Correspondence

Form CORRESP - Correspondence